South Korea’s ‘Super-Aging’ Challenge

South Korea’s ‘Super-Aging’ Challenge

Our Chief Korea and Taiwan Economist discusses the reforms needed to overcome Korea’s urgent demographic crisis.


----- Transcript -----


Welcome to Thoughts on the Market. I’m Kathleen Oh, Morgan Stanley’s Chief Korea and Taiwan Economist. Today I’ll discuss what’s needed to overcome Korea’s aging population crisis.

It’s Tuesday, Oct 15th, at 4 PM in Hong Kong.

South Korea faces some of the world's most challenging demographics and will officially become a super-aged society next year – that’s more than 20 percent of the population 65 or older. The implications of this are so significant that the Korean government recently declared a national emergency, and we don’t think this is overstating the case.

Korea’s low fertility rate is the primary culprit. In 2023 it plummeted to the lowest level globally and currently sits at 0.72. For reference, the total fertility rate of 2.1 children per woman is what’s necessary to maintain a stable population in general. By next year, Korea’s population will start declining and is projected to shrink by a third over the next 40 years as the working population halves. At this pace, the Bank of Korea forecasts that Korea’s potential growth could enter negative territory by 2040, down from 2 per cent in [20]24-25.

So why does Korea have such a record-low fertility rate? In the short term, there are two key drivers: First, the declining number of marriages during the pandemic drove a rapid drop in births; having children out of wedlock is taboo in Korea. Once weddings resumed in 2022, Korea saw a slight but insufficient rebound in births.

Second, housing prices have gone up 80 per cent in the past decade, which has discouraged young couples from having families. Families with first children feeling extra financial burdens to have [a] second child. Beyond the short term, structural factors have also played a role. After a compressed period of rapid economic growth, Koreans feel uncertain about the employment conditions and housing outlook.

Tackling the low fertility rate has been on Korean policymakers’ agenda for the past 20 years. The government has invested more than $320 billion into solving the demographic challenge. And while these efforts have certainly raised awareness, they have yet to overcome the crisis. And why? Because Korea has not addressed the root causes of the problem -- income uncertainty, high childcare and education costs.

It’s clear what’s needed here are structural reforms and Korea is clearly taking important steps towards overcoming the issue by tackling the fundamental problems now. Policymakers are working to reshape the pension system for the first time in 15 years. They are focusing on measures around improving work-life balance, reducing the gender wage gap, and increasing support for working parents. They are also considering lowering barriers to immigration, which could help alleviate talent shortages. They are also working on reducing the cost of private education. And finally, the government is also focused on improving the country’s capital market infrastructure. They are aiming to attract foreign investment, as well as to help households secure [a] source of asset accumulation, and lower borrowing costs for domestic players.

Of course, it’s impossible to quickly reverse the downtrend and positive change will require multiple years - even decades. Korea’s government has set a medium-term goal of returning the fertility rate to 1.0 by 2030, which would delay working population decline by five years. And if the fertility rate reaches 2.1, that would delay the decline in the workforce by 20 years. Conversely, if Korea’s fertility rate remains at the current rate of 0.72, the population will halve by 2065 and the economy will start contracting in 2040, a worst-case scenario that the government is determined to avoid.

Thanks for listening. If you enjoy the show, please leave us a review wherever you listen and share Thoughts on the Market with a friend or colleague today.

Avsnitt(1512)

Andrew Sheets: The New Definition of “Peak Oil”?

Andrew Sheets: The New Definition of “Peak Oil”?

Do tech-driven energy efficiencies—coupled with a shift in environmental attitudes—mean oil demand will fail to recover to pre-COVID levels?

9 Okt 20203min

Michael Zezas: Should Investors Prepare for No Stimulus?

Michael Zezas: Should Investors Prepare for No Stimulus?

With mixed signals coming from the White House and Congress, should investors be concerned about no further stimulus? Why there may still be good news.

7 Okt 20202min

Mike Wilson: Rate Scare on Deck?

Mike Wilson: Rate Scare on Deck?

With a U.S. fiscal stimulus deal looking more likely, the risk of long-term interest rates moving higher has now increased—a shift that could benefit recovery stocks.

5 Okt 20203min

Andrew Sheets: How Will Markets React to a Workable Vaccine?

Andrew Sheets: How Will Markets React to a Workable Vaccine?

For markets, a vaccine may be the most significant sign the world may return to a more normal future. But what are markets pricing in currently?

2 Okt 20202min

Special Episode: COVID-19 Vaccine - Trials and Tribulations

Special Episode: COVID-19 Vaccine - Trials and Tribulations

COVID-19 vaccines are navigating through the last stage of clinical trials, but hurdles still lie ahead for efficacy, distribution and FDA approval.

1 Okt 20209min

Michael Zezas: It’s the Results That Count

Michael Zezas: It’s the Results That Count

How will markets react if final U.S. election results take days or weeks? Head of U.S. Public Policy Research Michael Zezas shares advice for investors.

30 Sep 20202min

Mike Wilson: Near-term Correction; Long-term Recovery?

Mike Wilson: Near-term Correction; Long-term Recovery?

The recent correction may have been inevitable given rising risks for fiscal stimulus, a potential COVID-19 second wave and the upcoming election. But a resolution to these hurdles may also be possible longer-term.

28 Sep 20203min

Andrew Sheets: Four Reasons to Remain Patient

Andrew Sheets: Four Reasons to Remain Patient

Despite a needed correction in recent weeks, a suite of significant risks still hangs over U.S. markets. Chief Cross-Asset Strategist Andrew Sheets explains.

25 Sep 20202min

Populärt inom Business & ekonomi

badfluence
framgangspodden
varvet
rss-svart-marknad
rss-borsens-finest
uppgang-och-fall
rss-jossan-nina
affarsvarlden
bathina-en-podcast
lastbilspodden
fill-or-kill
borsmorgon
rss-inga-dumma-fragor-om-pengar
24fragor
avanzapodden
rss-kort-lang-analyspodden-fran-di
kapitalet-en-podd-om-ekonomi
rss-dagen-med-di
rss-en-rik-historia
tabberaset